Pacira Pharmaceuticals, Inc. focuses on providing non-opioid medications and advanced drug delivery technologies for pain management.

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

COM:PACIRA

Pacira Pharmaceuticals, Inc.

Last Close

16.87

31/10 20:00

Market Cap

946.75M

Beta: -

Volume Today

555.89K

Avg: -

locale

market

industry

website

ipo date

competitor of

Metrics